Vanilloid receptors: new insights enhance potential as a therapeutic target.
about
TRPV1: a target for next generation analgesicsTRPV1: on the road to pain reliefA non-pungent triprenyl phenol of fungal origin, scutigeral, stimulates rat dorsal root ganglion neurons via interaction at vanilloid receptorsCharacterization using FLIPR of rat vanilloid receptor (rVR1) pharmacologySuppression of tumor necrosis factor-α-induced nuclear factor κB activation and aromatase activity by capsaicin and its analog capsazepineRelation between measurements of cough severity.Ablation of rat TRPV1-expressing Adelta/C-fibers with resiniferatoxin: analysis of withdrawal behaviors, recovery of function and molecular correlates.Bladder sensory desensitization decreases urinary urgency.The antinociceptive and anti-inflammatory activities of caulerpin, a bisindole alkaloid isolated from seaweeds of the genus Caulerpa.Cough, cough receptors, and asthma in children.The diagnostic and therapeutic approach to idiopathic generalized pruritus.Effect of genetic deletion of the vanilloid receptor TRPV1 on the expression of Substance P in sensory neurons of mice with adjuvant-induced arthritis.Capsaicin-resistant arterial baroreceptors.In vivo pathway of thermal hyperalgesia by intrathecal administration of alpha,beta-methylene ATP in mouse spinal cord: involvement of the glutamate-NMDA receptor system.Resiniferatoxin-type phorboid vanilloids display capsaicin-like selectivity at native vanilloid receptors on rat DRG neurons and at the cloned vanilloid receptor VR1.Respiratory actions of vanilloid receptor agonists in the nucleus of the solitary tract: comparison of resiniferatoxin with non-pungent agents and anandamide.TRPV1 expression in acupuncture points: response to electroacupuncture stimulation.TRPV1 activation is not an all-or-none event: TRPV1 partial agonism/antagonism and its regulatory modulation.The overactive bladder: review of current pharmacotherapy in adults. Part 2: treatment options in cases refractory to anticholinergics.Developments in pharmacological therapy for the overactive bladder.Pharmacology of vagal afferent influences on disordered breathing during sleep.Oxidative challenges sensitize the capsaicin receptor by covalent cysteine modification.Transient receptor potential channels in pain and inflammation: therapeutic opportunities.Immunocytochemical localization of the vanilloid receptor 1 (VR1): relationship to neuropeptides, the P2X3 purinoceptor and IB4 binding sites.Capsaicin and Its Role in Chronic Diseases.The future of bladder control-intravesical drug delivery, a pinch of pepper, and gene therapy.The effect of intra-articular vanilloid receptor agonists on pain behavior measures in a murine model of acute monoarthritisFunctional and desensitizing effects of the novel synthetic vanilloid-like agent 12-phenylacetate 13-acetate 20-homovanillate (PPAHV) in the perfused rat hindlimb.Changes in osmolality sensitize the response to capsaicin in trigeminal sensory neurons.ACTH inhibits the capsaicin-evoked release of CGRP from rat adrenal afferent nerves.Homologous and heterologous desensitization of capsaicin and mustard oil responses utilize different cellular pathways in nociceptors.Developmental shift of vanilloid receptor 1 (VR1) terminals into deeper regions of the superficial dorsal horn: correlation with a shift from TrkA to Ret expression by dorsal root ganglion neurons.Contribution of capsaicin-sensitive sensory neurons to stress-induced increases in gastric tissue levels of prostaglandins in rats.Intravesical resiniferatoxin for patients with neurogenic detrusor overactivity.Early painful diabetic neuropathy is associated with differential changes in the expression and function of vanilloid receptor 1.Activation of transient receptor potential vanilloid 1 (TRPV1) by resiniferatoxin.Polygonifoliol, a new tirucallane triterpene from the latex of the seaside sandmat Euphorbia polygonifolia.Effect of the intravesical resiniferatoxin instillation evaluated by the ice provocative urodynamic study.Receptor nomenclature guidelines.TRPV1 gain-of-function mutation impairs pain and itch sensations in mice.
P2860
Q24649067-67EF54C9-DBDF-4FDB-869A-6027F58C3AC3Q24650367-F1035D7F-136C-4799-8368-359C17ED97B6Q24672318-EEEDAFA1-2A70-411F-B462-FE8F57AD4F2DQ28344380-1810428A-18F9-45CA-94B0-1D5AF005E628Q28394954-73174602-ACAB-453F-9C4F-74D641EB5BFAQ30494963-6D8F5A0B-5A2E-44FC-B98C-3F5C305C1FE2Q30497872-FA15F4D4-B29C-451E-A031-1262217C5F85Q30832054-5AA15BB9-CE87-4E07-BC7B-FBC7AAA502C6Q33605620-EDEEB191-C2E6-47B5-A2A0-133EBC36607BQ33687225-870DD406-E2B2-4CA9-94AF-F117E2915F0DQ33815789-8B06FBEE-906D-4337-B3FF-F01D093DFB83Q33888969-C6F8C700-BB8C-49C8-824E-445629324423Q34691294-86807DC2-8694-4209-A103-5D34AE8B5DBBQ35028905-740670A5-6C55-4BEB-8A63-ED43F92CD6A2Q35041549-DD9ED3CE-94E9-467B-807D-FFB7C6636FB6Q35044726-4F7364EB-AD59-4653-818A-32853B4BD46BQ35052608-46530632-8215-489D-AF2D-DB289E4CBA6DQ36168212-C5739321-F6D8-46AF-A67F-464F51901F5BQ36428476-92B422FA-0213-430A-A922-AFEFAD1F76E6Q36566857-B30D9C70-9015-4102-BFE2-42B505255AEAQ37097639-3340AEF6-BF37-478F-A402-682C988969F6Q37446570-D0405E05-6BC2-48BF-AF78-8268F39DBC64Q37709505-1695505D-69AC-44AA-94CB-9FD6B74582B1Q38326421-B398C6BB-02D7-4BA1-9A82-A382AE0F42DDQ38988562-05912FB7-529A-42E1-85F2-67B4EF21B28DQ40286823-BAAE7BC8-6B58-4666-B1C6-D437F335A3F9Q41448099-EB53361D-0B71-4338-91E4-1E981EE7BEA9Q42111832-93B55136-6FE2-4DB8-BB90-2B07446EFF1EQ42165817-9334A7C6-4D1A-40D8-8F1B-552834D6827AQ42497472-02F29922-A580-47F6-9503-5F7427EAAE90Q43151051-3EF0FA7A-4C7E-4055-ABF6-1DBE6E82B4FEQ43734928-9BD32F3F-58DC-4C25-B638-94F9C1B4343FQ44534187-ED49E43D-9880-4ABE-A455-13C9AF910240Q44803542-3C04DAAE-94DC-4CB9-8A16-7563EA65B112Q45129816-B97EE143-8443-47FB-A5B2-65A5EB123601Q46612877-7C2F07CF-71A5-4232-99E2-2FFA7D2A7593Q46701068-ACA64737-9D95-4B04-828B-DF403CD0FD5AQ46722776-535BCBD6-6082-45D8-ABF0-50149A0C9692Q47753674-EE62D51E-CD90-4E36-96DB-EB1E1E789013Q50102624-8BA3CE09-0A4F-421E-99A8-2344F3F245FB
P2860
Vanilloid receptors: new insights enhance potential as a therapeutic target.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Vanilloid receptors: new insights enhance potential as a therapeutic target.
@en
type
label
Vanilloid receptors: new insights enhance potential as a therapeutic target.
@en
prefLabel
Vanilloid receptors: new insights enhance potential as a therapeutic target.
@en
P1433
P1476
Vanilloid receptors: new insights enhance potential as a therapeutic target.
@en
P2093
Blumberg PM
Szallasi A
P304
P356
10.1016/S0304-3959(96)03202-2
P407
P577
1996-12-01T00:00:00Z